Introduction The effect of dermatological disease on patients' quality of life is a minimally addressed issue in Sri Lanka. One reason is the unavailability of a standardised measuring tool. This study was done to produce and validate a Sinhala version of the Dermatology Life Quality Index (DLQI), which is an internationally accepted quality of life measuring instrument.Methods The English version of the DLQI was translated according to standard procedures and the translated version was validated among 200 outpatients attending the dermatology clinics at the National Hospital of Sri Lanka and 30 healthy volunteers. The SF-36 was administered simultaneously to a random subsample Validation study of Sinhala version of the dermatology life quality index (DLQI)N PapersConclusions The DLQI (Sinhala) version is a simple, acceptable and reliable tool to measure the effect of dermatological diseases on quality of life.

No abstract

No abstract

No abstract

Kaposi's sarcoma (KS) is a rare angioproliferative neoplasm associated with human herpes virus type 8 (HHV-8) infection. Kaposi's sarcoma is an AIDS defining illness. Here we report the first case of cutaneous Kaposi's sarcoma reported in Sri Lanka in an AIDS patient in 2009.